Apellis Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.12.24	Deep Dive Into Apellis Pharmaceuticals Stock: Analyst Perspectives (20 Ratings) (Benzinga)
21.11.24	A Glimpse Into The Expert Outlook On Apellis Pharmaceuticals Through 20 Analysts (Benzinga)
05.11.24	Why Apellis Pharmaceuticals Stock Was Tumbling on Tuesday (MotleyFool)
04.11.24	The Latest Analyst Ratings For Apellis Pharmaceuticals (Benzinga)
04.11.24	Ausblick: Apellis Pharmaceuticals stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
16.10.24	Navigating 18 Analyst Ratings For Apellis Pharmaceuticals (Benzinga)
16.10.24	Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch (Benzinga)
20.09.24	What's Going With Apellis Pharmaceuticals Stock Friday? (Benzinga)
20.09.24	Apellis Says CHMP Confirms Negative Opinion For Pegcetacoplan In Geographic Atrophy, Stock Down (RTTNews)
13.09.24	Analyst Scoreboard: 15 Ratings For Apellis Pharmaceuticals (Benzinga)
08.08.24	Apellis Pharma Phase 3 VALIANT Study Of Pegcetacoplan Meets Primary Goal; Stock Up In Pre-market (RTTNews)
02.08.24	Critical Insights From Apellis Pharmaceuticals Analyst Ratings: What You Need To Know (Benzinga)
31.07.24	Ausblick: Apellis Pharmaceuticals verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net)
17.07.24	Peeling Back The Layers: Exploring Apellis Pharmaceuticals Through Analyst Insights (Benzinga)
28.06.24	What Analysts Are Saying About Apellis Pharmaceuticals Stock (Benzinga)
28.05.24	Expert Outlook: Apellis Pharmaceuticals Through The Eyes Of 15 Analysts (Benzinga)
08.05.24	In-Depth Examination Of 14 Analyst Recommendations For Apellis Pharmaceuticals (Benzinga)
06.05.24	Ausblick: Apellis Pharmaceuticals stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net)
15.04.24	Expert Ratings For Apellis Pharmaceuticals (Benzinga)
27.03.24	Decoding 15 Analyst Evaluations For Apellis Pharmaceuticals (Benzinga)
28.02.24	Deep Dive Into Apellis Pharmaceuticals Stock: Analyst Perspectives (18 Ratings) (Benzinga)
26.02.24	Ausblick: Apellis Pharmaceuticals vermeldet Zahlen zum jüngsten Quartal (finanzen.net)
22.02.24	Here's How Much You Would Have Made Owning Apellis Pharmaceuticals Stock In The Last 5 Years (Benzinga)
05.02.24	$1000 Invested In Apellis Pharmaceuticals 5 Years Ago Would Be Worth This Much Today (Benzinga)
30.01.24	Critical Insights From Apellis Pharmaceuticals Analyst Ratings: What You Need To Know (Benzinga)
26.01.24	Apellis: EU's CHMP Adopts Negative Opinion For Pegcetacoplan For GA; To Seek Re-Examination Of MAA (RTTNews)
09.01.24	Apellis Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (12 Ratings) (Benzinga)
14.12.23	Apellis Pharma Sinks On Indication Of CHMP's Negative Opinion On Pegcetacoplan (RTTNews)
31.10.23	Ausblick: Apellis Pharmaceuticals vermeldet Zahlen zum jüngsten Quartal (finanzen.net)
06.10.23	Pre-market Movers: COCH, TAOP, BEEP, NBTX, PXD… (RTTNews)
02.10.23	Apellis Pharmaceuticals Announces FDA Approval Of EMPAVELI Injector - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Apellis Pharmaceuticals Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten